The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Fixed-dose combination drugs: Innovative formulation and development strategies for bringing best-in-class products to market
Whitepaper
Fixed dose combination drugs (FDCs) have become an important alternative to monotherapy in the treatment of many diseases and conditions, including hypertension, diabetes, cancer, tuberculosis, asthma and COPD, and they hold promise for many more. Our tools can accurately identify effective combinations for many drugs on the market and help avoid those that may be problematic. By identifying potentially effective combinations or indications, our digital analytics can expedite time to market for novel therapies, benefitting patients and patent holders.